Fluorescein Sodium 2% Eye Drops
Brand names: Minims Fluorescein
Fluorescein sodium eye drops are a diagnostic dye used to reveal corneal epithelial damage, aid applanation tonometry and assist contact lens fitting.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
The dye fluoresces under blue light and collects where the corneal or conjunctival epithelium is disrupted, highlighting abrasions, ulcers and other surface defects.
Prescribing in practice
- Soft contact lenses should be removed before instillation because fluorescein permanently stains them, and reinsertion should be delayed as advised.
- It is a diagnostic agent only and does not treat the underlying condition, so abnormal findings need appropriate management.
- Single-use minims reduce the risk of contamination, which is important given fluorescein solutions can support microbial growth.
Monitoring
No systemic monitoring is required for topical use; interpret the staining pattern to guide diagnosis.
Counselling the patient
- Your tears may appear yellow-green briefly after the drops.
- Remove soft contact lenses beforehand and wait as advised before reinserting them.
- Report any persistent eye pain or visual disturbance.
Evidence & guidelines
Topical fluorescein is a long-established diagnostic dye for ocular surface assessment, with use guided by the SPC.
Reference: Emergency ophthalmology protocols; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Framingham Heart Failure Diagnostic Criteria · Heart Failure
- ADAPT Protocol for Cardiac Event Risk · Chest Pain
- Pericarditis Diagnostic Score (Imazio Criteria) · Pericardial Disease
- Brugada Syndrome Diagnostic Criteria · Channelopathy / Sudden Cardiac Death
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Sensitivity / Specificity / PPV / NPV Calculator · Diagnostic Test Evaluation
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme